In contrast to these findings, our study suggests a critical role of CD36 in CRC proliferation and tumor growth in vivo with both chemical inhibition via SSO as well as shRNA-mediated knockdown of CD36 in xenografts using multiple established cell lines. Here, CD36 is linked to neoplasm.